Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of 13-valent pneumococcal conjugate vaccine in healthy infants in Spain
2005-004772-21Phase 3Completed
- Sponsor
- Wyeth
- Start
- Jun 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pneumococcal disease comparing 13vPnC arm with 7vPnC active control arm (2 arms). Primary endpoints: Noninferiority of Meningitec immune response after infant series, Noninferiority of Infanrix hexa immune responses after 3-dose infant series and 1 more. Started Jun 2006; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccinepneumococcal 7-valent conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on 2005-004772-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004772-21.